Cardlytics, Inc. (NASDAQ:CDLX – Get Free Report) CEO Amit Gupta sold 5,964 shares of Cardlytics stock in a transaction that occurred on Friday, January 3rd. The stock was sold at an average price of $3.67, for a total transaction of $21,887.88. Following the transaction, the chief executive officer now directly owns 186,904 shares in the company, valued at $685,937.68. The trade was a 3.09 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.
Amit Gupta also recently made the following trade(s):
- On Thursday, October 24th, Amit Gupta sold 22,607 shares of Cardlytics stock. The stock was sold at an average price of $3.85, for a total transaction of $87,036.95.
Cardlytics Trading Down 1.4 %
NASDAQ CDLX opened at $3.44 on Wednesday. The company has a market cap of $174.83 million, a PE ratio of -0.56 and a beta of 1.53. Cardlytics, Inc. has a 12 month low of $2.89 and a 12 month high of $20.52. The stock has a 50 day moving average of $3.90 and a 200-day moving average of $4.78. The company has a current ratio of 1.18, a quick ratio of 1.18 and a debt-to-equity ratio of 2.40.
Wall Street Analyst Weigh In
A number of analysts recently commented on the stock. Craig Hallum upgraded shares of Cardlytics from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, November 6th. Needham & Company LLC restated a “hold” rating on shares of Cardlytics in a report on Thursday, November 7th. Finally, Evercore ISI assumed coverage on Cardlytics in a report on Friday, October 11th. They set an “in-line” rating and a $4.00 price objective on the stock. One research analyst has rated the stock with a sell rating, five have issued a hold rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $6.92.
View Our Latest Analysis on CDLX
Hedge Funds Weigh In On Cardlytics
Institutional investors have recently bought and sold shares of the business. Atom Investors LP acquired a new stake in shares of Cardlytics in the third quarter valued at approximately $33,000. SG Americas Securities LLC acquired a new stake in Cardlytics during the 3rd quarter valued at $45,000. Intech Investment Management LLC bought a new position in Cardlytics during the third quarter worth $47,000. Quadrature Capital Ltd acquired a new position in shares of Cardlytics in the third quarter valued at $63,000. Finally, BNP Paribas Financial Markets raised its position in shares of Cardlytics by 32.1% in the third quarter. BNP Paribas Financial Markets now owns 19,745 shares of the company’s stock valued at $63,000 after purchasing an additional 4,796 shares during the period. Institutional investors and hedge funds own 68.10% of the company’s stock.
About Cardlytics
Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.
Featured Stories
- Five stocks we like better than Cardlytics
- How to Effectively Use the MarketBeat Ratings Screener
- Disney: Forging a 3-Headed Sports Streaming Giant With Fubo Deal
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- How Buffett’s Best and Worst Stock Bets Have Fared 5 Years Later
- There Are Different Types of Stock To Invest In
- Bill Ackman’s Bold Case for Fannie Mae and Freddie Mac
Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.